Joel Gelfand, MD, MSCE, FAAD; Peter Dehnel, MD; and Steven Feldman, MD, PhD, provide an overview of psoriasis, including diagnosis, genetic influence, and progression ...

Depending on the definition used, there are large variations in the proportion of patients identified as having moderate-to-severe psoriasis. HealthDay News — Depending on the definition used, there ...

Psoriasis -- the chronic condition that causes red, scaly, itchy patches on your skin -- comes and goes. Your psoriasis can change in how serious it is and how often you have symptoms. Psoriasis ...

Please provide your email address to receive an email when new articles are posted on . Hematological parameters such as blood and platelet counts may have some utility in stratifying psoriasis ...

A panelist discusses how real-world evidence from a large cohort study (n = 31521) presented at AAD 2025 reveals notable differences in treatment patterns, discontinuation rates, persistence, and ...

NEW YORK — No fewer than four investigative therapies, ranging from an oral interleukin-23 receptor antagonist to oral tyrosine kinase inhibitors and a long-acting biologic, have the potential to ...

A novel oral drug for plaque psoriasis that targets the same inflammatory pathway as currently available parenteral therapies showed promise for treating moderate to severe disease in a phase 2 ...